Self-reported medication adherence among patients with diabetes or hypertension, Médecins Sans Frontières Shatila refugee camp, Beirut, Lebanon: A mixed-methods study

Author:

Mohamad MariamORCID,Moussally Krystel,Lakis ChantalORCID,El-Hajj Maya,Bahous Sola,Peruzzo Carla,Reid Anthony,Edwards Jeffrey K.

Abstract

Introduction Low adherence to medications, specifically in patients with Diabetes (DM) and Hypertension (HTN), and more so in refugee settings, remains a major challenge to achieving optimum clinical control in these patients. We aimed at determining the self-reported medication adherence prevalence and its predictors and exploring reasons for low adherence among these patients. Methods A mixed-methods study was conducted at Médecins Sans Frontières non-communicable diseases primary care center in the Shatila refugee camp in Beirut, Lebanon in October 2018. Data were collected using the validated Arabic version of the 8-items Morisky Medication Adherence Scale (MMAS-8) concurrently followed by in-depth interviews to explore barriers to adherence in patients with DM and/or HTN. Predictors of adherence were separately assessed using logistic regression with SPSS© version 20. Manual thematic content analysis was used to analyze the qualitative data. Results Of the 361 patients included completing the MMAS, 70% (n = 251) were moderately to highly adherent (MMAS-8 score = 6 to 8), while 30% (n = 110) were low-adherent (MMAS-8 score<6). Patients with DM-1 were the most likely to be moderately to highly adherent (85%; n = 29). Logistic regression analysis showed that patients with a lower HbA1C were 75% more likely to be moderately to highly adherent [(OR = 0.75 (95%CI 0.63–0.89), p-value 0.001]. Factors influencing self-reported moderate and high adherence were related to the burden of the disease and its treatment, specifically insulin, the self-perception of the disease outcomes and the level of patient’s knowledge about the disease and other factors like supportive family and healthcare team. Conclusion Adherence to DM and HTN was good, likely due to a patient-centered approach along with educational interventions. Future studies identifying additional factors and means addressing the barriers to adherence specific to the refugee population are needed to allow reaching optimal levels of adherence and design well-informed intervention programs.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Astrazeneca, Plan International. Curbing the Non-Communicable disease epidemic in the Middle East and North Africa: Prevention Among Young People Is the Key. 2017 Dec. http://www.ncdchild.org/media/1288/prb-ncd-middle-east-and-north-africa.pdf

2. World Health Organization (WHO). Noncommunicable Diseases (NCD) Country Profiles, Lebanon. 2018. https://www.google.com/search?biw=1280&bih=578&sxsrf=ALeKk00Gm_Ug3NLCuparABuAcQvPAz3V8A%3A1605571233712&ei=oRKzX4yMK8TFgwfAxqXIAw&q=Noncommunicable+Diseases+%28NCD%29+Country+Profiles%2C+Lebanon+2018&oq=Noncommunicable+Diseases+%28NCD%29+Country+Profiles%2C+Lebanon+2018&gs_lcp=CgZwc3ktYWIQAzoECAAQRzoECCMQJzoICCEQFhAdEB5QwyJY6SZg8yhoAHACeACAAY4BiAGZBZIBAzAuNZgBAKABAaoBB2d3cy13aXrIAQjAAQE&sclient=psy-ab&ved=0ahUKEwjM4K_4oojtAhXE4uAKHUBjCTkQ4dUDCA0&uact=5

3. Treating Syrian refugees with diabetes and hypertension in Shatila refugee camp, Lebanon: Médecins Sans Frontières model of care and treatment outcomes;M Kayali;Confl Health,2019

4. Adnan Kisa. Adherence to long term therapies: Evidence for action. https://www.who.int/chp/knowledge/publications/adherence_report_fin.pdf

5. Improving adherence to medication in adults with diabetes in the United Arab Emirates;MMM Al-Haj Mohd;BMC Public Health,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3